Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Van Geel

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Multiple Sclerosis and Related Disorders|March 17, 2019
Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosisK van der Hiele, D A M van Gorp, M A P Heerings, et al.
Cancers|September 10, 2021
Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE RegistrySanne Nieuwenhuizen, Madelon Dijkstra, Robbert S Puijk, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2026
Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumabYan Wang, Laura H Bukkems, Johan G C van Hasselt, et al.
International Journal of Cancer|October 16, 2023
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancerArd van Veelen, G D Marijn Veerman, Marjon V Verschueren, et al.
Cancer Research|June 18, 2016
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal CancerDaniele Oddo, Erin M Sennott, Ludovic Barault, et al.
Bone|May 11, 2017
The association between insulin use and volumetric bone mineral density, bone micro-architecture and bone strength of the distal radius in patients with type 2 diabetes - The Maastricht studyE A C de Waard, J H M Driessen, J J A de Jong, et al.
Targeted Oncology|April 20, 2023
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung CancerRob Ter Heine, Michel M van den Heuvel, Berber Piet, et al.
Multiple Sclerosis and Related Disorders|June 15, 2026
Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosisP C G Molenaar, D L Weir, E P J Arnoldus, et al.
NPJ Genomic Medicine|November 16, 2021
Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseqR Koster, R D Brandão, D Tserpelis, et al.
BMC Cancer|August 30, 2025
Development and provider assessment of a new oncology network with care pathways for gastrointestinal cancer patients: the collaborative approachBritte H E A Ten Haaft, Eefje van Kessel, Mark I van Berge Henegouwen, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Multiple Sclerosis and Related Disorders|March 17, 2019
Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosisK van der Hiele, D A M van Gorp, M A P Heerings, et al.
Cancers|September 10, 2021
Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE RegistrySanne Nieuwenhuizen, Madelon Dijkstra, Robbert S Puijk, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2026
Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumabYan Wang, Laura H Bukkems, Johan G C van Hasselt, et al.
International Journal of Cancer|October 16, 2023
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancerArd van Veelen, G D Marijn Veerman, Marjon V Verschueren, et al.
Cancer Research|June 18, 2016
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal CancerDaniele Oddo, Erin M Sennott, Ludovic Barault, et al.
Bone|May 11, 2017
The association between insulin use and volumetric bone mineral density, bone micro-architecture and bone strength of the distal radius in patients with type 2 diabetes - The Maastricht studyE A C de Waard, J H M Driessen, J J A de Jong, et al.
Targeted Oncology|April 20, 2023
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung CancerRob Ter Heine, Michel M van den Heuvel, Berber Piet, et al.
Multiple Sclerosis and Related Disorders|June 15, 2026
Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosisP C G Molenaar, D L Weir, E P J Arnoldus, et al.
NPJ Genomic Medicine|November 16, 2021
Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseqR Koster, R D Brandão, D Tserpelis, et al.
BMC Cancer|August 30, 2025
Development and provider assessment of a new oncology network with care pathways for gastrointestinal cancer patients: the collaborative approachBritte H E A Ten Haaft, Eefje van Kessel, Mark I van Berge Henegouwen, et al.
Pageof 18